Results 71 to 80 of about 12,974 (209)

Pneumomediastinum and Pneumothorax as Rare Complications of Ruptured Pulmonary Hydatid Cyst: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Ruptured hydatid cyst should be considered when encountering spontaneous pneumothorax and pneumomediastinum, especially in young patients in regions with high prevalence of hydatid cyst. Awareness of atypical signs ensures instant diagnosis, guiding appropriate surgical and medical treatment to prevent serious complications.
Farzaneh Akbari   +5 more
wiley   +1 more source

Multisystem Langerhans' cell histiocytosis (Hand-Schüller-Christian disease) in an adult: a case report and review of the literature [PDF]

open access: yes, 2018
Langerhans' cell histiocytosis (LCH) is a rare and enigmatic clonal disorder that affects mainly children. It is characterized by single or multiple granulomatous mass lesions composed of cells with the Langerhans' cell phenotype.
Jaques, B.   +3 more
core  

Erdheim Chester disease – 25 year history with early CNS involvement [PDF]

open access: yes, 2016
We report a case of Erdheim-Chester disease (ECD) with a 25-year history following initial presentation with diabetes insipidus and brainstem involvement.
Cohen, N   +5 more
core   +2 more sources

The clinicopathological characteristics and differential diagnosis of histiocytosis

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2015
The histiocytosis is divided into Langerhans' cell histiocytosis (histiocytosis X) and non-Langerhans' cell histiocytosis (NLCH). The former mainly occurs in lymphatic hematopoietic tissue and often involves central nervous system (CNS).
Shi-zhu YU
doaj  

A CASE OF HISTIOCYTOSIS IN THE PATIENT SUSPECTED TO HAVE PULMONARY TUBERCULOSIS

open access: yesТуберкулез и болезни лёгких, 2019
The article describes the clinical case of Langerhans cell histiocytosis with lesions in lungs and flat bones in a 40-year-old smoker. During 4 years, all stages of the disease were followed.
M. A. Karnaushkina   +2 more
doaj   +1 more source

Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples [PDF]

open access: yes, 2016
This review article deals with the analysis and the detection of the morphological features associated with somatic mutations, mostly BRAF(V600E) mutation, on both cytological and histological samples of carcinomas.
Abildgaard   +112 more
core   +1 more source

Hidden Insights: Comprehensive Radiological Analysis of Four Skeletal Populations From 13th–19th Century Southern Finland Reveals Neoplastic and Other Lesions Invisible on Bone Surfaces

open access: yesInternational Journal of Osteoarchaeology, Volume 36, Issue 1, Page 196-206, January/February 2026.
ABSTRACT This study aims to identify lesions confined to the internal structures of bones. A radiographic analysis was performed on 219 archaeological, historical period skeletons from southern Finland. Although the study examines nearly all preserved skeletal elements using plain radiographs, it does not incorporate computed tomography.
Kati Salo   +2 more
wiley   +1 more source

Letterer–Siwe Disease (LSD): A Case Report

open access: yesSudan Journal of Medical Sciences, 2018
Background: Letterer–Siwe Disease (LSD) is one of the variants of Langerhans cell histiocytosis (LCH), which is considered as a rare disease that affects many systems in the body; it is characterized by monoclonal migration and proliferation of specific ...
Suad H. H.   +3 more
doaj   +1 more source

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1. [PDF]

open access: yes, 2015
The histiocytoses are rare tumors characterized by the primary accumulation and tissue infiltration of histiocytes and dendritic cells. Identification of the activating BRAFV600E mutation in Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis
Arceci, Robert J   +8 more
core   +3 more sources

Early Experience of Treprostinil Dry‐Powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Tertiary Referral Center

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT A dry powder inhaler (DPI) formulation of treprostinil was FDA‐approved in March 2022 for patients with pulmonary arterial hypertension or pulmonary hypertension associated with ILD (PH‐ILD). In this letter we describe our real‐world single‐center experience using Treprostinil DPI in patients with PH‐ILD patients within our first year of using
Jordin L. Rice   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy